These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19429283)

  • 1. Vaginal gel adsorption and retention by human vaginal cells: visual analysis by means of inorganic and organic markers.
    Braga PC; Dal Sasso M; Spallino A; Sturla C; Culici M
    Int J Pharm; 2009 May; 373(1-2):10-5. PubMed ID: 19429283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual analysis of vaginal cell binding and retention of a gynecological douche.
    Braga PC; Spallino A; Dal Sasso M; Sturla C; Culici M
    Minerva Ginecol; 2010 Feb; 62(1):7-13, 13-6. PubMed ID: 20186111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.
    Karimunnisa S; Atmaram P
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an immortalized human vaginal epithelial cell line.
    Rajan N; Pruden DL; Kaznari H; Cao Q; Anderson BE; Duncan JL; Schaeffer AJ
    J Urol; 2000 Feb; 163(2):616-22. PubMed ID: 10647697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezrin is a key element in the human vagina.
    Fadiel A; Lee HH; Demir N; Richman S; Iwasaki A; Connell K; Naftolin F
    Maturitas; 2008 May; 60(1):31-41. PubMed ID: 18486367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels.
    Perioli L; Ambrogi V; Venezia L; Pagano C; Ricci M; Rossi C
    Colloids Surf B Biointerfaces; 2008 Oct; 66(1):141-5. PubMed ID: 18621512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
    Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging.
    Barnhart KT; Pretorius ES; Timbers K; Shera D; Shabbout M; Malamud D
    Contraception; 2005 May; 71(5):357-61. PubMed ID: 15854637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation studies of benzydamine mucoadhesive formulations for vaginal administration.
    Perioli L; Ambrogi V; Venezia L; Giovagnoli S; Pagano C; Rossi C
    Drug Dev Ind Pharm; 2009 Jul; 35(7):769-79. PubMed ID: 19337872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial to determine the distribution of four topical gel formulations in the human vagina.
    Barnhart K; Kulp JL; Rosen M; Shera DM
    Contraception; 2009 Apr; 79(4):297-303. PubMed ID: 19272499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence of Lactobacillus plantarum P 17630 in soft-gel capsule formulation versus Döderlein's bacillus in tablet formulation to vaginal epithelial cells.
    Bonetti A; Morelli L; Campominosi E; Ganora E; Sforza F
    Minerva Ginecol; 2003 Jun; 55(3):279-84, 284-7. PubMed ID: 14581876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse.
    Barnhart KT; Pretorius ES; Timbers K; Shera D; Shabbout M; Malamud D
    Contraception; 2004 Dec; 70(6):498-505. PubMed ID: 15541413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen.
    Geonnotti AR; Peters JJ; Katz DF
    J Pharm Sci; 2005 Aug; 94(8):1705-12. PubMed ID: 15986472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections.
    Ahmad FJ; Alam MA; Khan ZI; Khar RK; Ali M
    Acta Pharm; 2008 Dec; 58(4):407-19. PubMed ID: 19103575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of vaginal films for mucosal delivery of nitric oxide.
    Yoo JW; Acharya G; Lee CH
    Biomaterials; 2009 Aug; 30(23-24):3978-85. PubMed ID: 19409611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The optimal analysis of MRI data to quantify the distribution of a microbicide.
    Barnhart KT; Pretorius ES; Shera DM; Shabbout M; Shaunik A
    Contraception; 2006 Jan; 73(1):82-7. PubMed ID: 16371301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adhesion of Escherichia coli onto quartz, hematite and corundum: extended DLVO theory and flotation behavior.
    Farahat M; Hirajima T; Sasaki K; Doi K
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):140-9. PubMed ID: 19665879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy.
    Brown J; Hooper G; Kenyon CJ; Haines S; Burt J; Humphries JM; Newman SP; Davis SS; Sparrow RA; Wilding IR
    Pharm Res; 1997 Aug; 14(8):1073-8. PubMed ID: 9279891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women.
    Nel AM; Coplan P; van de Wijgert JH; Kapiga SH; von Mollendorf C; Geubbels E; Vyankandondera J; Rees HV; Masenga G; Kiwelu I; Moyes J; Smythe SC
    AIDS; 2009 Jul; 23(12):1531-8. PubMed ID: 19550287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI of the female pelvis using vaginal gel.
    Brown MA; Mattrey RF; Stamato S; Sirlin CB
    AJR Am J Roentgenol; 2005 Nov; 185(5):1221-7. PubMed ID: 16247138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.